Overview The Study of AZD8529 for Smoking Cessation in Female Smokers Status: Completed Trial end date: 2017-01-01 Target enrollment: Participant gender: Summary To evaluate the efficacy and safety of AZD8529 for smoking cessation in female smokers. Phase: Phase 2 Details Lead Sponsor: National Institute on Drug Abuse (NIDA)